Lemborexant Treatment of Insomnia Linked to Epilepsy
University of Manitoba
Summary
The goal of this clinical trial is to assess whether Lemborexant can improve sleep in patients with epilepsy.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Sleep-related focal epilepsy * Contraception Exclusion Criteria: * Changes in antiseizure medication 1 month before study protocol or during study protocol * Concomitant medications per SUNRISE1 * Individuals with hepatic impairment * Female participants who are pregnant or breastfeeding * Individuals with compromised respiratory function * Individuals with a history of complex sleep-related behaviour * Individuals with rare hereditary diseases of galactose intolerance such as galactosemia or glucose-galactose malabsorption * Individuals with a history of dependence or…
Interventions
- DrugLemborexant
Drug is administered
- DrugPlacebo
Drug is administered
Locations (2)
- Duke UniversityDurham, North Carolina
- Health Sciences CentreWinnipeg, Manitoba